Elanco Animal Health (ELAN) Short-Term Debt repayments (2021 - 2025)

Elanco Animal Health's (ELAN) quarterly Short-Term Debt repayments came in at $85.0 million in Q2 2025, down 57.5% year-on-year from $200.0 million in Q2 2024, and up 112.5% quarter-over-quarter from $40.0 million in Q1 2025.

Elanco Animal Health (ELAN) Short-Term Debt repayments (2021 - 2025) Analysis & Trends

Elanco Animal Health has disclosed Short-Term Debt repayments across 5 years of filings, most recently posting $85.0 million for Q2 2025.

  • Short-Term Debt repayments for Q2 2025 came in at $85.0 million, down 57.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $85.0 million (down 64.58% YoY), and the FY2025 annual result was $125.0 million, down 50.0% from the prior year.
  • Short-Term Debt repayments came in at $85.0 million for Q2 2025 at Elanco Animal Health, up from $40.0 million in the prior quarter.
  • In the past five years, Short-Term Debt repayments ranged from a high of $575.0 million in Q2 2022 to a low of -$813.0 million in Q4 2022.
  • The 5-year median for Short-Term Debt repayments is $80.0 million (2024), against an average of $54.8 million.
  • Across the five-year window, Short-Term Debt repayments surged 1050.0% in 2022 and slumped 164.0% in 2024, its largest moves.
  • Elanco Animal Health's Short-Term Debt repayments stood at $100.0 million in 2021, then slumped by 913.0% to -$813.0 million in 2022, then jumped by 108.86% to $72.0 million in 2023, then grew by 11.11% to $80.0 million in 2024, then rose by 6.25% to $85.0 million in 2025.
  • The last three Short-Term Debt repayments figures came in at $85.0 million (Q2 2025), $40.0 million (Q1 2025), and $80.0 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Short-Term Debt repayments (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Liquidia 5.64 Bn 5.42 Bn 121.79 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 85.00 Mn
Jun 30, 2025 85.00 Mn
Mar 31, 2025 40.00 Mn
Mar 31, 2025 40.00 Mn
Dec 31, 2024 80.00 Mn
Dec 31, 2024 80.00 Mn
Sep 30, 2024 -80.00 Mn
Sep 30, 2024 -80.00 Mn
Jun 30, 2024 200.00 Mn
Jun 30, 2024 200.00 Mn
Mar 31, 2024 50.00 Mn
Mar 31, 2024 50.00 Mn
Dec 31, 2023 72.00 Mn
Dec 31, 2023 72.00 Mn
Sep 30, 2023 125.00 Mn
Sep 30, 2023 125.00 Mn
Dec 31, 2022 -813.00 Mn
Dec 31, 2022 -813.00 Mn
Sep 30, 2022 75.00 Mn
Sep 30, 2022 75.00 Mn